FERRAU', Oscar
 Distribuzione geografica
Continente #
NA - Nord America 565
EU - Europa 432
AS - Asia 90
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.089
Nazione #
US - Stati Uniti d'America 562
IE - Irlanda 132
SE - Svezia 108
CN - Cina 78
UA - Ucraina 54
GB - Regno Unito 49
DE - Germania 35
FI - Finlandia 19
IT - Italia 19
BE - Belgio 14
IN - India 10
CA - Canada 3
CL - Cile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.089
Città #
Dublin 132
Jacksonville 118
Chandler 108
Nyköping 65
Ann Arbor 52
Ashburn 45
Beijing 42
Lancaster 37
Cambridge 19
Medford 19
Princeton 19
Des Moines 18
Brussels 14
Woodbridge 14
Salerno 12
Boardman 10
Dearborn 10
Pune 8
Jinan 6
Haikou 5
Auburn Hills 4
Hangzhou 4
San Mateo 4
Los Angeles 3
Ottawa 3
Washington 3
Changsha 2
Chicago 2
Guangzhou 2
Messina 2
Taizhou 2
Zhengzhou 2
Ardabil 1
Chongqing 1
Fuzhou 1
Hanover 1
Hefei 1
Hyderabad 1
Lanzhou 1
Leawood 1
Milan 1
Mountain View 1
Nanchang 1
Nanjing 1
Ningbo 1
Norwalk 1
Palermo 1
Phoenix 1
Saint Louis 1
Seattle 1
Shenyang 1
Taiyuan 1
Tianjin 1
Wilmington 1
Totale 808
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 85
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 79
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 78
TOPICAL TREATMENT OF DISTAL ACTIVE ULCERATIVE COLITIS WITH BECLOMETHASONE DIPROPIONATE OR MESALAZINE 76
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 75
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 62
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? 61
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 55
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 55
Ten year follow-up of patients with chronic hepatitis C treated with interferon 52
Studio comparativo dgeli effetti della bromopride e della metoclopramide sulla funzione ipotalamo-ipofisaria. 52
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 51
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 50
Tamoxifen in the treatment of Hepatocellular Carcinoma: 5-year results of the CLIP-1 multicentre randomized controlled trial 49
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 46
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 45
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 44
Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence ofAscites and Variceal Progression in Cirrhosis. 42
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 40
Totale 1.097
Categoria #
all - tutte 3.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/2020194 36 18 1 17 1 12 25 17 3 34 29 1
2020/2021130 19 2 31 6 3 20 2 17 2 12 10 6
2021/2022140 3 26 5 5 5 2 7 3 2 21 22 39
2022/2023404 26 44 27 24 37 34 2 34 160 3 10 3
2023/202490 7 14 4 9 6 33 0 15 0 2 0 0
Totale 1.097